Effect of therapeutic targeting of xCT on USP15/SMAD-driven gemcitabine resistance in KRAS-mutant pancreatic cancer. TNTD and OS in a validation cohort composed of data from two prospective studies, ...
Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results